KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
01 1ENZALUTAMIDE PREMIX (20% W/W)
01 1India
01 1Active
01 1Complete
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2025-10-09
Pay. Date : 2025-09-12
DMF Number : 41429
Submission : 2025-03-27
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is ENZALUTAMIDE PREMIX (20% W/W), with a corresponding US DMF Number 41429.
Remarkably, this DMF maintains an Active status since its submission on March 27, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 09, 2025, and payment made on September 12, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
